Search research articles
Contact Us
Filters
Showing results (381-390 of 512) with videos related to
Page
of 52
Sort By:
Future Oncology (London, England)
|
March 6, 2023
TRUST-II: a global phase II study of taletrectinib in <i>ROS1</i>-positive non-small-cell lung cancer and other solid tumors
Misako Nagasaka, Yuichiro Ohe, Caicun Zhou, et al.
JAMA Oncology
|
January 13, 2018
Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer
Laura Mezquita, Edouard Auclin, Roberto Ferrara, et al.
Cancers
|
August 7, 2021
Association of the Lung Immune Prognostic Index with Immunotherapy Outcomes in Mismatch Repair Deficient Tumors
Edouard Auclin, Perrine Vuagnat, Cristina Smolenschi, et al.
JCO Precision Oncology
|
October 31, 2022
Implementing the European Society for Medical Oncology Scale for Clinical Actionability of Molecular Targets in a Comprehensive Profiling Program: Impact on Precision Medicine Oncology
Patricia Martin-Romano, Laura Mezquita, Antoine Hollebecque, et al.
Clinical Lung Cancer
|
March 10, 2025
Brief Report: Real-World Clinical Utility of Next-Generation Sequencing of Circulating Tumor DNA for Patients With Advanced Lung Squamous Cell Carcinoma (SQUIN)
Miguel García-Pardo, Marta García de Herreros, Juan Carlos Laguna, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 24, 2022
Molecular profiling of non-small-cell lung cancer patients with or without brain metastases included in the randomized SAFIR02-LUNG trial and association with intracranial outcome
Alice Mogenet, Fabrice Barlesi, Benjamin Besse, et al.
The Journal of Liquid Biopsy
|
March 3, 2025
Anti-ALK autoantibodies in patients with ALK-positive Non-Small Cell Lung Cancer (NSCLC): A monocentric experience
Claudia Parisi, José Carlos Benitez, Hélène Lecourt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 29, 2025
First-Line Mobocertinib Versus Platinum-Based Chemotherapy in Patients With <i>EGFR</i> Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer in the Phase III EXCLAIM-2 Trial
Pasi A Jänne, Bin-Chao Wang, Byoung Chul Cho, et al.
Science Advances
|
November 8, 2023
Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8<sup>+</sup> T cells in patients with advanced NSCLC
Marie Naigeon, Matthieu Roulleaux Dugage, François-Xavier Danlos, et al.
EJNMMI Research
|
August 1, 2020
<sup>18</sup>F-FDG PET and DCE kinetic modeling and their correlations in primary NSCLC: first voxel-wise correlative analysis of human simultaneous [18F]FDG PET-MRI data
Florent L Besson, Brice Fernandez, Sylvain Faure, et al.
Page
of 52
Search research articles
Search
Showing results (381-390 of 512) with videos related to
Sort By:
Page
of 52
Future Oncology (London, England)
|
March 6, 2023
TRUST-II: a global phase II study of taletrectinib in <i>ROS1</i>-positive non-small-cell lung cancer and other solid tumors
Misako Nagasaka, Yuichiro Ohe, Caicun Zhou, et al.
JAMA Oncology
|
January 13, 2018
Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer
Laura Mezquita, Edouard Auclin, Roberto Ferrara, et al.
Cancers
|
August 7, 2021
Association of the Lung Immune Prognostic Index with Immunotherapy Outcomes in Mismatch Repair Deficient Tumors
Edouard Auclin, Perrine Vuagnat, Cristina Smolenschi, et al.
JCO Precision Oncology
|
October 31, 2022
Implementing the European Society for Medical Oncology Scale for Clinical Actionability of Molecular Targets in a Comprehensive Profiling Program: Impact on Precision Medicine Oncology
Patricia Martin-Romano, Laura Mezquita, Antoine Hollebecque, et al.
Clinical Lung Cancer
|
March 10, 2025
Brief Report: Real-World Clinical Utility of Next-Generation Sequencing of Circulating Tumor DNA for Patients With Advanced Lung Squamous Cell Carcinoma (SQUIN)
Miguel García-Pardo, Marta García de Herreros, Juan Carlos Laguna, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 24, 2022
Molecular profiling of non-small-cell lung cancer patients with or without brain metastases included in the randomized SAFIR02-LUNG trial and association with intracranial outcome
Alice Mogenet, Fabrice Barlesi, Benjamin Besse, et al.
The Journal of Liquid Biopsy
|
March 3, 2025
Anti-ALK autoantibodies in patients with ALK-positive Non-Small Cell Lung Cancer (NSCLC): A monocentric experience
Claudia Parisi, José Carlos Benitez, Hélène Lecourt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 29, 2025
First-Line Mobocertinib Versus Platinum-Based Chemotherapy in Patients With <i>EGFR</i> Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer in the Phase III EXCLAIM-2 Trial
Pasi A Jänne, Bin-Chao Wang, Byoung Chul Cho, et al.
Science Advances
|
November 8, 2023
Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8<sup>+</sup> T cells in patients with advanced NSCLC
Marie Naigeon, Matthieu Roulleaux Dugage, François-Xavier Danlos, et al.
EJNMMI Research
|
August 1, 2020
<sup>18</sup>F-FDG PET and DCE kinetic modeling and their correlations in primary NSCLC: first voxel-wise correlative analysis of human simultaneous [18F]FDG PET-MRI data
Florent L Besson, Brice Fernandez, Sylvain Faure, et al.
Page
of 52